4820.T
The company operates in the software industry, providing software solutions primarily within the health care technology sector.
Business. 4820.T is a software company operating within the Technology sector, specifically focused on software development and services. The firm utilizes a subscription-based revenue model, aligning with industry standards for tracking metrics such as annual recurring revenue and net revenue retention. Specific details regarding operating segments, headquarters location, and primary stock exchange listings are not provided in the available data. Consequently, the company is described at the industry level without geographic or segment-specific breakdowns.
Analyst recommendations
1 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Peers
- EarningsQ2 2026 earnings (expected)2026-07-28 · estimated · ServiceNow (NOW)
- EarningsQ2 2026 earnings (expected)2026-08-28 · estimated · Salesforce (CRM)
- Macro
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-07-08 · AU
- Rate decisionBank of Canada rate decision (press conf.)2026-07-15 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-07-16 · EU
- Rate decisionBank of Japan rate decision (press conf.)2026-07-16 · JP
- Rate decisionFederal Reserve rate decision (press conf.)2026-07-29 · US
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
4820.T is a software company operating within the Technology sector, specifically focused on software development and services. The firm utilizes a subscription-based revenue model, aligning with industry standards for tracking metrics such as annual recurring revenue and net revenue retention. Specific details regarding operating segments, headquarters location, and primary stock exchange listings are not provided in the available data. Consequently, the company is described at the industry level without geographic or segment-specific breakdowns.
The company maintains a strong liquidity position, with a current ratio of 2.24 and cash and equivalents amounting to 7,847,000,000 JPY. The price-to-book ratio is 1.7, and the price-to-tangible-book ratio is also 1.7, indicating a moderate valuation relative to its book value. The company's return on equity is 12.02%, and its return on assets is 8.91%, both of which are strong indicators of profitability and efficient use of assets.
The company's operating income is 2,987,000,000 JPY, and its net income is 2,452,000,000 JPY, reflecting a healthy margin and profitability. The gross profit is 11,879,000,000 JPY, which is a significant portion of its revenue of 23,658,000,000 JPY. These figures suggest that the company is performing well compared to industry standards, although specific cohort medians are not provided for direct comparison.
The company's revenue is concentrated in the health care technology sector, as indicated by its sector classification industry classification. There is no detailed breakdown of geographic exposure or segment performance provided in the available data. The company's growth trajectory is positive, with a mean recommendation of 1.00 from analysts, indicating a strong buy sentiment. The last actual EPS was 35.44 JPY, which is higher than the mean EPS estimate of 28.90 JPY.
The company's risk assessment indicates low liquidity and dilution risks, with no immediate filing-based liquidity or dilution flags detected. The debt-to-equity ratio is 0.03, suggesting a conservative capital structure with minimal leverage. The company's free cash flow is negative at -593,000,000 JPY, which may indicate reinvestment in the business or capital expenditures.
Recent events and filings do not show any significant changes or risks that would impact the company's operations or financial health. The company's capital expenditure is -1,381,000,000 JPY, indicating a significant investment in long-term assets.
- The company has a strong liquidity position with a current ratio of 2.24 and substantial cash reserves.
- The company's profitability is reflected in its return on equity of 12.02% and return on assets of 8.91%.
- The company's operating and net income figures indicate a healthy margin and profitability.
- Analysts have a strong buy sentiment towards the company, with a mean recommendation of 1.00.
- The company's capital structure is conservative, with a low debt-to-equity ratio of 0.03.
- margin_outlook_rationale: The company's strong gross profit margin and operating income suggest a positive outlook for maintaining or improving margins.
- rd_outlook_rationale: The company's investment in capital expenditures indicates a commitment to long-term growth and innovation.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 28,90 |
| Revenue | —no estimate | —no estimate | 23,5B JPY |
| Operating income | —no estimate | —no estimate | —no estimate |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- 4820.T Market data — financials · 2026-05-26
- EM Systems Co Ltd Market data — analyst estimates · 2026-05-26